Be sure to check this site for even more session coverage from the 82nd Scientific Sessions throughout the summer.
The site will be updated weekly through August 2022.
As type 2 diabetes medications have become more effective, management goals have become more ambitious, said Rodolfo J. Galindo, MD, FACE. It is no longer enough to lower A1C. The ideal type 2 diabetes medication can control glycemia with low risk of hypoglycemia and produce beneficial effects on beta cell function, weight loss, and cardiorenal function.
Read more
Carol H. Wysham, MD, says there is serious therapeutic inertia at play as patients often remain in poor glycemic control for more than seven years before intensification of treatment. Yet repeated studies show that up-titrating GLP-1 receptor agonist dosing improves glycemic outcomes as well as loss and maintenance of weight. Read more
Obesity can lead to insulin resistance, which sets the stage for the development of beta amyloid plaques and tau tangles in the brain, both hallmarks of Alzheimer’s disease. Some early trials of inhaled insulin in people with type 2 diabetes show improved memory, Auriel A. Willette, PhD, MS, and Vera Novak, MD, PhD, explained. Read more
An expert panel including Paul McGuigan, RN, CDCES, stressed that creating a continuum of care and support starting in high school, including promoting health insurance literacy, is key to setting up young people with type 2 diabetes to successfully manage their disease as they transition to adulthood. Read more
Afternoon training improves glucose sensitivity, increases fat loss, and increases work performance while reducing nocturnal blood glucose levels, said Juleen R. Zierath, PhD, one of the panelists discussing the molecular mechanisms known to affect the circadian rhythms of liver function. Read more
Anastasia Albanese-O’Neill, PhD, APRN, CDCES, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting's virtual platform through September 5, 2022. Read more
Carl G. Streed Jr, MD, MPH, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting's virtual platform through September 5, 2022. Read more
Raphael P.H. Meier, MD, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting's virtual platform through September 5, 2022. Read more
Paolo S. Silva, MD, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting's virtual platform through September 5, 2022. Read more
Shuibing Chen, PhD, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting's virtual platform through September 5, 2022. Read more
Whether you attended the 82nd Scientific Sessions in person or virtually, you can claim continuing education credits now! Complete session evaluations on the ADA's Professional Education Portal by following the instructions on the page. Credit must be claimed by October 7, 2022.
Vera Novak, MD, PhD, discusses the research behind this presentation which begins at 8:10 a.m. CT on Tuesday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Maria J. Redondo, MD, PhD, MPH, discusses the research behind this presentation which begins at 8:00 a.m. CT on Tuesday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Dongyin Guan, PhD, discusses the research behind this presentation which begins at 7:30 a.m. CT on Tuesday. A livestream and on-demand recording are available at ADA2022.org.
Read More
The ADA presented its 2022 National Scientific & Health Care Achievement Awards to a distinguished group of diabetes researchers, clinicians, and educators on Monday, June 6, at the 82nd Scientific Sessions in New Orleans. Anna L. Gloyn, DPhil, received the Outstanding Scientific Achievement Award for her groundbreaking research.
Read more
A distinguished panel of experts reviewed the latest information on the development of weekly insulins, oral insulins, glucose-sensitive insulin, and the role of biosimilars and interchangeable insulins on Monday, June 6. Michael A. Weiss, MD, PhD, MBA, discussed the development of glucose-sensitive insulin, or “smart insulin,” that can be activated through the use of a synthetic “switch” that can be opened or closed using a simple sugar sensor. Read more
Four weight loss researchers discussed the value of behavioral therapy, intensive lifestyle interventions, and pharmacotherapy during a Scientific Sessions symposium on Sunday, June 5. “There’s quite a bit of evidence showing that individuals who self-monitor over time generally are the best in terms of maintenance of behaviors and weight,” said Hollie Raynor, PhD, RD, LDN. Read more
An expert panel examined several barriers limiting the use of diabetes technology in under-resourced communities at the 82nd Scientific Sessions. “Regardless of their socioeconomic status, everyone deserves access to the right technology at the right time, especially in a chronic condition like diabetes,” said Vivian N. Ayuk, PharmD, CDCES. Read more
A panel of clinical leaders discussed the importance of educating hospital staff about diabetes management and care during a Scientific Sessions symposium on Monday, June 6. “It really does affect the patient experience when we don’t do an excellent job managing their glycemia, and that’s the point of education,” said Leigh B. Bak, MSN, APRN, ACNS-BC, CDCES. Read more
Racial, ethnic, and socioeconomic disparities that limit access to diabetes medications and technologies lead to poor glycemic control, diabetic emergencies, and adverse cardiovascular outcomes, according to Sara Jane Cromer, MD, one of three presenters in a symposium on Monday, June 6, that examined disparities in the use of diabetes medications and technologies. Read more
In the final episode of the ADA Meeting News podcast series, Chair of the 82nd Scientific Sessions Meeting Planning Committee Dana Dabelea, MD, PhD, sits down with host Nick Gerik to preview Tuesday's program and key events taking place outside the session rooms, and discuss on-demand access to session recordings at the meeting.
Listen Now Read more
After SURMOUNT-1 trial results were reported at the Scientific Sessions on Saturday and made worldwide headlines, a special session on Tuesday, June 7, will showcase more than 20 tirzepatide abstracts presented over the five days of the meeting. “Attendees are seeing and hearing data that is being presented for the first time here in New Orleans,” said Katherine R. Tuttle, MD, FASN, FACP, FNKF, one of the session’s presenters. Read more
Genomic analysis, single-cell sequencing, and epigenomic approaches are uncovering new mechanisms in the development and progression of diabetic kidney disease. A panel of researchers, including Jose C. Florez, MD, PhD, will provide an update on the latest discoveries. Read more
Richard David Leslie, MBBS, MRCS, MD, FRCP, FAoP, says diabetes should be rethought. He will open a unique symposium on the final day of the 82nd Scientific Sessions that will examine various aspects of heterogeneity in diabetes. Read more
Three neurological researchers—Auriel Willette, PhD, Vera Novak, MD, PhD, and Valory Pavlik, PhD (left to right)—will discuss the links between diabetes and cognitive decline and explore possible interventions during a Scientific Sessions symposium on Tuesday, June, 7. Read more
Once thought of as nonfunctional vestigial relics of evolutionary history, cilia are emerging as critical components in multiple signaling pathways that control sight, smell, renal function, feeding behavior and obesity, skeletal formation, and, most recently, insulin secretion and glucose homeostasis. “Cilia biology is going to explode in diabetes,” predicts Jing Hughes, MD, PhD. Read more
Four researchers, including Dongyin Guan, PhD (left), Kristin Eckel-Mahan, PhD, will discuss how circadian misalignment impacts metabolic health during a Scientific Sessions symposium on Tuesday, June 7. Read more
Audrey V. Parent, PhD, discusses the research behind this presentation which begins at 5:30 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.
Read More
“What’s unique about these new classes of drugs is that they’re not glucose-lowering drugs. They’re cardio-renal risk-reducing agents that happen to lower glucose if your kidney function is normal or reasonable,” said George Bakris, MD, who will present during the symposium, which begins at 4:30 p.m. CT on Monday.
Read More
Cardiovascular disease is recognized as one of the most common complications of diabetes. Clinicians have long viewed coronary arterial disease and atherosclerosis as the major culprits, but heart failure has emerged as a larger problem—and one that’s more difficult to manage, according to Rong Tian, MD, PhD, who will present during a symposium at 4:30 p.m. CT Monday.
Read More
Four cardiologists, including Yi Tan, PhD (left), and Harold E. Bays, MD, will discuss the underlying mechanisms, diagnosis, and treatment of cardiomyopathy, a familiar yet underappreciated complication of diabetes during a symposium at 4:30 p.m. CT on Monday. “My sense is we are on the cusp of some really interesting times in cardiomyopathy in diabetes,” Dr. Bays said.
Read More
The ADA and the European Association for the Study of Diabetes will release the latest consensus recommendations on managing hyperglycemia in type 2 diabetes during a special joint session beginning at 4:30 p.m. CT on Monday. The symposium will be co-chaired by ADA Chief Scientific and Medical Officer Robert A. Gabbay, MD, PhD, and EASD President Stefano Del Prato, MD.
Read More
Gary Lewis, MD, FRCPC, is the recipient of the 2022 Edwin Bierman Award. This award is presented to a leading scientist who has made outstanding contributions in the field of diabetes-related macrovascular complications and related risk factors. Dr. Lewis will present the Edwin Bierman Award Lecture on Monday at 4:30 p.m. CT. An on-demand recording will be available at ADA2022.org after the session.
This year's 5K @ ADA run/walk brought together participants in New Orleans and around the globe in a virtual challenge from June 1 to June 5. To learn more about the challenge or to view results and photos, visit ADA5K.com.
Julia E. Blanchette, PhD, RN, BC-ADM, CDCES, discusses the research behind this presentation which begins at 3:45 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Vincent Prevot, PhD, discusses the research behind this presentation which begins at 2:45 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Paul McGuigan, RN, discusses the research behind this presentation which begins at 2:15 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.
Read More
In a symposium at 2:15 p.m. CT on Monday, four diabetes care and education specialists, including Paul McGuigan, RN, CDCES, and Julia E. Blanchette, PhD, RN, BC-ADM, CDCES, will discuss both time-tested and novel approaches to improve the quality-of-life of young people living with diabetes.
Read More
This symposium will include presentations on high-dose GLP-1 RAs in treatment of type 2 diabetes, a look at the role of GLP-1 co-agonists, the availability of high-dose semaglutide for treatment of obesity, and the potential of GLP-1 RAs in cardiometabolic care. The session begins at 2:15 p.m. CT on Monday in Great Hall A at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Amy K. Mottl, MD, MPH, FASN, will open the joint session, which brings together experts from various disciplines in an effort to improve screening, uptake of practice guidelines, and patient outcomes. The symposium begins at 2:15 p.m. on Monday.
Read More
Research examining central nervous system control of systemic metabolism suggests that the CNS plays an important, and perhaps a dominant role in the pathogenesis and progression of at least some forms of diabetes. Four leaders in the field, including Vincent Prevot, PhD, and Sarah Stanley, MB, BCh, PhD, will review the latest findings at 2:15 p.m. CT on Monday.
Read MoreFrances M. Ashcroft, DBE, FRS, FMedSci, recipient of the ADA’s 2022 Banting Medal for Scientific Achievement, shares more about how she came to be involved in the science of diabetes. Dr. Ashcroft presented the Banting Medal lecture, Metabolic Regulation of Insulin Secretion in Health and Disease, on Sunday at the Scientific Sessions. A recording can be viewed on-demand at ADA2022.org.
Noel C. Barengo, MD, PhD, MPH, discusses the research behind this presentation which begins at 12:25 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.
Read More
This interest group discussion will feature presentations on current epidemiological approaches to study determinants of health in diabetes using big data, as well as a look at implementing effective interventions. The session begins at 12:00 p.m. CT on Monday in La Nouvelle Orleans Ballroom B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Ania M. Jastreboff, MD, PhD, shares details about the results of the SURMOUNT-1 phase 3 obesity trial of tirzepatide. Dr. Jastreboff helped present findings Saturday during the Scientific Sesssions, and a recording of that presentation can be found at ADA2022.org.
Ebony B. Carter, MD, MPH, discusses the research behind this presentation which begins at 12:05 p.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Stop by the bookstore in Lobby A on the first level of the convention center until 6:45 p.m. Monday. The store reopens at 7:30 a.m. Tuesday and will be open until 10 a.m. Purchases support diabetes research, advocacy, and education programs. Browse online anytime at ShopDiabetes.org.
This interest group discussion will feature presentations on optimizing EMR integration of CGM data. The session begins at 12:00 p.m. CT on Monday in Great Hall B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Anna Gloyn, DPhil, shares thoughts about the work that led her to be named the recipient of the ADA's 2022 Outstanding Scientific Achievement Award. View her Monday award lecture live on on-demand at ADA2022.org.
This special session, which will recognize outstanding achievement in diabetes science and care, begins at 10:15 a.m. CT on Monday in Hall F at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Hertzel C. Gerstein, MD, MSc, FRCPC, is the recipient of the 2022 Outstanding Achievement in Clinical Diabetes Research Award. This award is presented to an individual for outstanding contributions in patient-oriented clinical outcomes research that have had significant impact on diabetes prevention and treatment.
Ashby F. Walker, PhD, from the ADA's Health Disparities Committee, shares insights about some of the science and topics that attendees can see represented at the 82nd Scientific Sessions Poster Hall, open until 2 p.m. CT Monday, and virtual e-Poster page, which can be viewed anytime through ADA2022.org.
Anna Gloyn, DPhil, is the recipient of the 2022 Outstanding Scientific Achievement Award. This award recognizes research in diabetes that demonstrates independence of thought, originality, and significance of discovery. Dr. Gloyn will present the Outstanding Scientific Achievement Award Lecture on Monday in a session beginning at 10:15 a.m. CT in Hall F at the convention center. Livestream available at ADA2022.org.
Juan R. Alvarez Dominguez, PhD, discusses the research behind this presentation which begins at 9:00 a.m. CT on Monday. A livestream and on-demand recording are available at ADA2022.org.
Read More
This symposium will include presentations on limitations in access to new diabetes therapies across different ethnicities, a look at out-of-pocket costs and access to diabetes therapies under Medicare Part D, and an examination of racial and ethnic disparities in the use of diabetes technology. The session will begin at 8:00 a.m. CT on Monday in Great Hall B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
This symposium will include presentations on weekly insulins on the horizon, oral insulins, glucose-sensitive insulin, and the role of biosimilars and interchangeable insulins. The session will begin at 8:00 a.m. on Monday in Great Hall A at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Guillermo E. Umpierrez, MD, CDCES, FACP, FACE, ADA President, Medicine & Science, discussed the need for individualized glucose management for non-ICU hospital patients with type 2 diabetes on Sunday, June 5, at the 82nd Scientific Sessions.
Read more
Frances M. Ashcroft, DBE, FRS, FMedSci, recipient of the ADA’s 2022 Banting Medal for Scientific Achievement, discussed a novel approach—inhibiting glucokinase activity to improve insulin secretion—for treating type 2 diabetes during her award lecture on Sunday, June 5. Read more
Linda DiMeglio, MD, MPH, David A. D’Alessio, MD, and Silvia Corvera, MD (left to right), reviewed some of the key advances in diabetes research and care during the annual Year in Review session. Read more
Five behavioral health specialists discussed the effects of stigma in diabetes care during an afternoon symposium on Saturday, June 4. Alan M. Delamater, PhD, opened the symposium by recounting his 40-year journey in behavioral diabetes research as he presented the annual Richard R. Rubin Award Lecture. Read more
The recent emergence of effective anti-obesity medications raises the question of whether weight loss, rather than glucose control, should be considered the primary target for intervention in type 2 diabetes. Ildiko Lingvay, MD, MPH, MSCS, and Jeffrey I. Mechanick, MD, debated that question at the 82nd Scientific Sessions. Read more
Losing weight, no matter how much or how little, has health benefits for obese people with type 2 diabetes. And the more they lose, the better the outcome, said Priya Sumithran, PhD, one of three panelists in a Scientific Session symposium that explored the use of lifestyle interventions, bariatric surgery, and pharmacotherapy to manage obesity and type 2 diabetes. Read more
In the fourth episode of the ADA Meeting News podcast series, Chair of the 82nd Scientific Sessions Meeting Planning Committee Dana Dabelea, MD, PhD, sits down with host Nick Gerik to preview Monday's program and highlight key events taking place outside the session rooms.
Listen Now Read more
Research examining central nervous system control of systemic metabolism suggests that the CNS plays an important, and perhaps a dominant role in the pathogenesis and progression of at least some forms of diabetes. Four leaders in the field, including Vincent Prevot, PhD, and Sarah Stanley, MB, BCh, PhD, will review the latest findings at the Scientific Sessions. Read more
Cardiovascular disease is recognized as one of the most common complications of diabetes. Clinicians have long viewed coronary arterial disease and atherosclerosis as the major culprits, but heart failure has emerged as a larger problem—and one that’s more difficult to manage, according to Rong Tian, MD, PhD. Read more
Four cardiologists, including Yi Tan, PhD (left), and Harold E. Bays, MD, will discuss the underlying mechanisms, diagnosis, and treatment of cardiomyopathy, a familiar yet underappreciated complication of diabetes. “My sense is we are on the cusp of some really interesting times in cardiomyopathy in diabetes,” Dr. Bays said. Read more
Lauren B. Beach, JD, PhD, discusses the research behind this presentation which begins at 6:00 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.
Read More
In a symposium beginning at 4:30 p.m. CT on Sunday, four experts, including Satish K. Garg, MD, and Holly Willis, PhD, RDN, CDCES, will discuss practical strategies to improve eating habits and optimize the growing number of insulin-dosing options to improve glucose control, increase time in range, reduce A1C, and lower the risk of long-term complications from poor glucose control.
Read More
Jamie Feldman, MD, will chair a Scientific Sessions symposium at 4:30 p.m. CT on Sunday examining diabetes, metabolic health, and clinical care among people who are lesbian, gay, bisexual, transgender, gender diverse, queer, or questioning.
Read More
Diabetic peripheral neuropathy (DPN) remains undertreated, according to Loretta Vileikyte, MD, PhD (left), who will discuss the psychosocial impact of painful DPN during a symposium beginning at 4:30 p.m. CT on Sunday. Stephanie Eid, PhD, will discuss efforts to develop mechanism-based therapies that impact peripheral neuropathy before irreversible nerve damage occurs.
Read More
Janet B. McGill, MD, MA, FACP, is the recipient of the 2022 Outstanding Physician Clinician in Diabetes Award. This award is presented to a physician clinician for exceptional clinical knowledge and expertise in the care of patients with diabetes.
Shahzeb Khan, MD, MSc, discusses the research behind this presentation which begins at 3:45 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.
Read MoreADA special interest group leaders have presented awards to young investigators who are showcasing research at the 82nd Scientific Sessions. Visit the Poster Hall, open until 6:30 p.m. CT Sunday and from 7:30 a.m. to 2:00 p.m. CT Monday, to view these and the hundreds of other posters at this year's meeting.
Anna L. Gloyn, DPhil, discusses the research behind this presentation which begins at 3:45 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Jane E.B. Reusch, MD, is the recipient of the 2022 Albert Renold Award. This award is presented to an individual whose career is distinguished by outstanding achievements in mentorship and in the development of a robust environment for diabetes research.
“Heart failure has been a forgotten disorder because the basic and translational science models were created with atherosclerosis in diabetes leading to ischemic heart attacks and strokes. But if you look at the real world, people with diabetes develop heart failure and their mortality is horrific,” said Eldrin F. Lewis, MD, MPH, who will be presenting in this symposium, which starts at 2:15 p.m. on Sunday.
Read More
Visit the bookstore in Lobby A on the first level of the convention center until 6:45 p.m. Sunday. The store reopens at 7:30 a.m. Monday and will be open during daytime hours through Tuesday. Purchases support diabetes research, advocacy, and education programs. Browse online anytime at ShopDiabetes.org.
Amit R. Majithia, MD, discusses the research behind this presentation which begins at 2:15 p.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Jill Norris, MPH, PhD, is the recipient of the 2022 Kelly West Award for Outstanding Achievement in Epidemiology. This award recognizes significant contributions to the field of diabetes epidemiology. Dr. Norris will present the Kelly West Award Lecture on Sunday at 2:15 p.m. CT in Great Hall A at the convention center. Livestream available at ADA2022.org.
This interest group discussion will include a presentation on integrated omics for prediction and management of cardiovascular diseases in people with diabetes. The session will begin at 12:00 p.m. CT on Sunday in Great Hall A at the convention center. A livestream and on-demand recording are available at ADA2022.org.
This interest group discussion will include a presentation on the nuts and bolts of managing a professionally recognized DSMES outpatient program. The session will begin at 12:00 p.m. CT on Sunday in La Nouvelle Orleans Ballroom B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
More than 1,000 posters with the latest investigative findings are on display at the 82nd Scientific Sessions. Presenters will be discussing their research from 12:00 p.m. to 1:00 p.m. on Sunday and 12:00 p.m. to 1 p.m. on Monday. All posters will be viewable in-person until 6:30 p.m. on Sunday and from 7:30 a.m. to 2 p.m. on Monday. The 2022 ePosters can be viewed at anytime through ADA2022.org.
This interest group discussion will include presentations on the social determinants of health and access to eye care, as well as the role of telehealth and artificial intelligence to address disparities in eye care among people with diabetes. The session will begin at 12:00 p.m. CT on Sunday in Great Hall B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Visit the American Diabetes Association's booth at the Scientific Sessions Exhibit Hall, which is open from 10:00 a.m. to 4:00 p.m. CT on Sunday and 10:00 a.m. to 2:00 p.m. CT on Monday.
Stop by the Exhibit Hall at the convention center to engage with industry and advocacy. The hall is open until 4 p.m. on Sunday and from 10 a.m. to 2 p.m. on Monday. Virtual exhibits can be viewed at anytime on ADA2022.org.
ADA President of Medicine & Science Guillermo E. Umpierrez, MD, CDCES, FACP, FACE, will address the 82nd Scientific Sessions at 10:15 a.m. CT on Sunday in Hall F at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Frances M. Ashcroft, DBE, FRS, FMedSci, is the recipient of the 2022 Banting Medal for Scientific Achievement. This award recognizes significant, long-term contributions to the understanding, treatment, or prevention of diabetes. Dr. Ashcroft will present the Banting Medal Lecture on Sunday in a session beginning at 10:15 a.m. CT in Hall F at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Eric Senneville, MD, PhD, is the recipient of the 2022 Roger Pecoraro Award. This award recognizes contributions to the understanding of the detection, treatment, and prevention of diabetic foot complications. Dr. Senneville will present the Roger Pecoraro Award Lecture on Sunday in a session beginning at 8:00 a.m. CT in Room 356 at the convention center. An on-demand recording will be available at ADA2022.org after the session.
Jasmine D. Gonzalvo, PharmD, CDCES, BC-ADM, discusses the research behind this presentation which begins at 9:00 a.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Anne Peters, MD, discusses the research behind this presentation which begins at 8:00 a.m. CT on Sunday. A livestream and on-demand recording are available at ADA2022.org.
Read More
In a symposium at 8:00 a.m. CT on Sunday, June 5, Hollie Raynor, PhD, RD, and three other expert presenters will review the latest lessons learned for maximizing weight loss maintenance in the U.S. National Diabetes Prevention Program.
Read More
Linda A. DiMeglio, MD, MPH, David A. D’Alessio, MD, and Silvia Corvera, MD, will summarize a year’s worth of discovery, innovation, and paradigm shifts in diabetes research and care during the annual Year in Review symposium at 8:00 a.m. CT on Sunday.
Read More
In a symposium at 8:00 a.m. CT on Sunday, a multidisciplinary panel including diabetes care and education specialists Jasmine D. Gonzalvo, PharmD, CDCES, BC-ADM (left), and Vivian N. Ayuk, PharmD, CDCES, will discuss educational strategies to help underserved populations overcome barriers to technology access.
Read More
Study investigators reported first results from the SURMOUNT-1 trial on Saturday, June 4, at the Scientific Sessions. The findings indicate that tirzepatide may be a potential therapeutic option for individuals living with obesity, said Louis J. Aronne, MD.
Read more
Otis W. Kirksey, PharmD, RPh, CDCES, BC-ADM, ADA President, Health Care & Education, discussed his dedication to the diabetes community on Saturday, June 4, saying that improving the lives of people with diabetes takes equal parts of dedication and hard work. Read more
Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, received the ADA’s 2022 Outstanding Educator in Diabetes Award at the 82nd Scientific Sessions. Diabetes self-management education and support (DSMES) should be the standard-of-care for every person with diabetes, she said. Read more
Davida F. Kruger, MSN, APN-BC, BC-ADM, told women at the Saturday afternoon symposium that if they’re not invited to the table, show up anyway—with a chair. And keep moving that chair closer and closer to the table. Read more
Physical activity is an integral part of the diabetes management toolbox, but not everyone responds to physical activity the same way or has the ability to exercise regularly. A panel of exercise scientists, including Carlos Crespo, PhD, examined how health disparities and sex differences impact physical activity during a morning symposium on Saturday, June 4. Read more
During an afternoon symposium on Friday, June 3, a diverse interprofessional panel of experts—including an epidemiologist, a health services researcher, a historian, and a medical anthropologist—shared their work and insights on the role of race and racism in diabetes research and diabetes care. “Implicit bias training alone does not work in terms of being sustainable. It has to be accompanied by systemic structural interventions—they go hand in hand,” said Marshall Chin, MD, MPH. Read more
In the third episode of the new ADA Meeting News podcast series, Chair of the 82nd Scientific Sessions Meeting Planning Committee Dana Dabelea, MD, PhD, sits down with host Nick Gerik to preview Sunday's program and highlight key events taking place outside the session rooms.
Listen Now Read more
Four experts, including Satish K. Garg, MD, and Holly Willis, PhD, RDN, CDCES, will discuss practical strategies to improve eating habits and optimize the growing number of insulin-dosing options to improve glucose control, increase time in range, reduce A1C, and lower the risk of long-term complications from poor glucose control. Read more
Jamie Feldman, MD, will chair a Scientific Sessions symposium examining diabetes, metabolic health, and clinical care among people who are lesbian, gay, bisexual, transgender, gender diverse, queer, or questioning. Read more
The ADA and the European Association for the Study of Diabetes published a consensus report on precision diabetes medicine in 2020. Scientific Sessions attendees will get an update on this joint initiative during a special symposium at 4:00 p.m. CT on Saturday. John M. Dennis, PhD, and David Kerr, MD, are two of the featured presenters.
Read More
Anny Xiang, PhD, is the recipient of the 2022 Norbert Freinkel Award. This award recognizes outstanding contributions to the understanding and treatment of diabetes and pregnancy. Dr. Xiang will present the Norbert Freinkel Award Lecture on Saturday in a session beginning at 4:00 p.m. CT in Room RO7 at the convention center. An on-demand recording will be available at ADA2022.org after the session.
Steven J. Russell, MD, PhD, shares more about the Insulin-Only Bionic Pancreas Pivotal Trial and the results of the study, which were presented Friday during a mini-symposium at the Scientific Sessions. An on-demand recording of that session is available at ADA2022.org
Krista A. Varady, PhD, discusses the research behind this presentation which begins at 4:00 p.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Nicolai Jacob Wewer Albrechtsen, MD, PhD, discusses the research behind this presentation which begins at 2:45 p.m. on Saturday. A livestream and on-demand recording are available at ADA2022.org.
Read More
This symposium will include presentations on diabetes' image problem, experiences of weight stigma among people with type 2 diabetes, and engaging health care professionals in changing their language to reduce stigma. The session will begin at 1:45 p.m. CT on Saturday in La Nouvelle Orleans Ballroom B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
This current issues session will feature competing arguments for either obesity or glucose control as the primary target of treatment in type 2 diabetes, as well as a question and discussion period at the end. The session will begin at 1:45 p.m. CT on Saturday in Great Hall A at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, and Michelle F. Magee, MD, MB, BCh, LRCPSI, will review the updated national standards for diabetes self-management education and support during a symposium at 1:45 p.m. Saturday. A companion session will outline the revised certification program for certified diabetes care and education specialists.
Read More
Ildiko Lingvay, MD, MPH, MSCS, discusses the research behind this presentation which begins at 1:45 p.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.
Read More
This symposium will include remarks from NIDDK Director Griffin P. Rodgers, MD, MACP, and feature presentations focused on reducing disparities, targeting food insecurity, tackling environmental social determinants of health, and more. The session will begin at 1:45 p.m. CT on Saturday in La Nouvelle Orleans Ballroom C at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Meeting attendees In New Orleans share the topics, sessions, and experiences that they're most looking forward to during the five days of the ADA's 82nd Scientific Sessions.
Don't forget to check out the Exhibit Hall at the convention center, where you can see the latest products and services from industry. The hall is open until 4 p.m. Saturday, 10 a.m. to 4 p.m. on Sunday, and 10 a.m. to 2 p.m. on Monday. Virtual exhibits can be viewed at anytime on ADA2022.org.
Alan Delamater, PhD, ABPP, is the recipient of the 2022 Richard R. Rubin Award. This award recognizes outstanding contributions to the study and understanding of behavioral aspects of diabetes. Dr. Delamater will present the Richard R. Rubin Award Lecture on Saturday in a session beginning at 1:45 p.m. CT in La Nouvelle Orleans Ballroom B at the convention center. Livestream available at ADA2022.org.
Explore some of the more than 1,000 posters at the 82nd Scientific Sessions. Presenters will be discussing their research from 11:30 a.m. to 12:30 p.m. on Saturday, 12:00 p.m. to 1:00 p.m. on Sunday, and 12:00 p.m. to 1 p.m. on Monday. All posters will be on display until 6 p.m. on Saturday, from 7:30 a.m. to 6:30 p.m. on Sunday, and from 7:30 a.m. to 2 p.m. on Monday. The 2022 ePosters can be viewed at anytime through ADA2022.org
Nuzhat Chalisa, MD, FACE, discusses the research behind this presentation which begins at 11:55 a.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Windy Cole, DPM, CWSP, discusses the research behind this presentation which begins at 11:35 a.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.
Read MoreThe recipient of the 2022 Outstanding Educator in Diabetes Award, Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, shares thoughts about the importance of her work as a diabetes care and education specialist. View her Saturday award lecture live or on-demand at ADA2022.org.
This mini-symposium will feature presentations from the Women's Interprofessional Network of the American Diabetes Association and will include a panel discussion. The session will begin at 11:30 a.m. CT on Saturday in La Nouvelle Orleans Ballroom B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
ADA President of Health Care & Education Otis W. Kirksey, PharmD, RPh, CDCES, BC-ADM, shares the importance of treating patients with care and empathy. View his Saturday address to the Scientific Sessions live or on-demand at ADA2022.org.
Visit the bookstore in Lobby A on the first level of the convention center until 6:15 p.m. Saturday. The store reopens at 7:30 a.m. Sunday and will be open during daytime hours through Tuesday. Purchases support diabetes research, advocacy, and education programs. Browse online anytime at ShopDiabetes.org.
A full program awaits on the second day of the meeting. Scientific Sessions Planning Committee Chair Dana Dabelea, MD, PhD, previews some of the day's highlights.
There’s no shortage of things to do or sights to see in New Orleans. Founded by the French and later ruled by the Spanish, this one-of-a-kind city is jam-packed with European, Southern, Creole, and Cajun influences.
Read More
Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, is the recipient of the 2022 Outstanding Educator in Diabetes Award. This award recognizes a distinguished health professional who has made outstanding educational efforts in the field of diabetes. Ms. Hess-Fischl will present the Outstanding Educator in Diabetes Award Lecture on Saturday in a session beginning at 10:15 a.m. CT in Hall F at the convention center. Livestream available at ADA2022.org.
ADA President of Health Care & Education Otis W. Kirksey, PharmD, RPh, CDCES, BC-ADM, will address the 82nd Scientific Sessions at 10:15 a.m. CT on Saturday in Hall F at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Mohammad S. Kuchay, MD, DM, discusses the research behind this presentation which begins at 9:00 a.m. CT on Saturday. A livestream and on-demand recording are available at ADA2022.org.
Read More
This symposium will feature background on tirzepatide, the study design and objectives, results, and implications for the present and future of care. The session will begin at 8:00 a.m. CT on Saturday in Great Hall B at the convention center. A livestream and on-demand recording are available at ADA2022.org.
Factors such as sex, gender, age, ethnicity, education, and living environment affect a person’s physical activity. Jane E. Yardley, PhD, and three other experts will share strategies for prescribing physical activity that are feasible and sustainable for various patient groups during a symposium at 8:00 a.m. on Saturday.
Read More
The prevalence of diagnosed and undiagnosed diabetes ranges from 17.4% of African Americans to 13.6% of White Non-Hispanic Americans, but the outcomes are far different. Nationwide, Black people with diabetes are 2.2-fold more likely to die than White people, according to Joshua J. Joseph, MD, MPH, FAHA.
Read more
During a Friday afternoon session, an interprofessional panel of experts provided their perspectives and reviewed some of the most current literature on improving outcomes across the cardio-renal-metabolic spectrum of diabetes. “In the tsunami of diabetes, multidisciplinary, interdisciplinary therapy is essential if we are going to continue to improve outcomes,” said Neda Rasouli, MD. Read more
Alison Evert, MS, RDN, CDCES (left), and Maureen Chomko, RD, CDCES, addressed several nutrition controversies—from net carbs to fad diets to meal and snack frequency—during a mini-symposium on the first day of the 82nd Scientific Sessions. Read more
Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES (left), and Michelle F. Magee, MD, MB, BCh, LRCPSI, will review the updated national standards for diabetes self-management education and support. A companion session will outline the revised certification program for certified diabetes care and education specialists. Read more
The ADA and the European Association for the Study of Diabetes published a consensus report on precision diabetes medicine in 2020. Scientific Sessions attendees will get an update on this joint initiative during a special symposium on Saturday, June 4. John M. Dennis, PhD (left), and David Kerr, MD, are two of the featured presenters. Read more
James D. Johnson, PhD (left), and Steven E. Kahn, MB, ChB, debated whether hyperinsulinemia is the primary defect that results in type 2 diabetes during a mini-symposium on Friday, June 3. “The big question is whether insulin resistance is primary or if hyperinsulinemia stimulates insulin resistance,” Dr. Johnson said. Read more
It’s hard to go wrong dining out in the Big Easy, a city with rich culinary traditions. But if you’re not comfortable leaving things to chance, check out our restaurant recommendations before heading out for a bite.
Read More
Maureen Gannon, PhD, is the recipient of the 2022 Lois Jovanovic Transformative Woman in Diabetes Award. This award is presented to a woman who has made a significant impact in diabetes care, research, education, or public health.
Laurel H. Messer, PhD, MPH, RN, CDCES, discusses the research behind this presentation which begins at 5:15 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.
Read More
Katharine R. Barnard-Kelly, PhD, discusses the research behind this presentation which begins at 4:39 p.m. CT on Friday. A livestream and on-demand recording are available at ADA2022.org.
Read More